Transient Amplifying Cells and Oral Mucosa
To date, no studies have been conducted to identify stem cells or TA cells that reside in the oral cavity. Identification of either the stem cell or TA cell location(s) will provide a better understanding of normal and abnormal epithelial growth including tissue regeneration in the oral cavity. Oral mucosa is a very unique and dynamic tissue that is under constant environmental stresses that often requires rapid turnover of epithelium and connective tissue. Literature suggests that oral epithelial stem cells are fully capable of continuously regenerating during their lifetime but fail to distinguish stem cells from other basal cells. 4 Furthermore, the location and activity of stem cells in oral premalignant and malignant epithelial disease has not been clarified in the literature.
Epithelial dysplastic lesions also referred to as "pre-cancerous" lesions undergo alterations in the TA cell pool that potentially leads to sustained abnormal growth of tissue. [5] [6] [7] [8] [9] When dysplastic lesions are surgically excised with microscopically tumor free borders, the lesion may still recur up to 30% of the time. 10, 11 This evidence leads us to speculate that oral epithelial premalignant and malignant lesions arise as a consequence of altered stem cells and/or TA cells. 12 This correlates with the previous discussion of skin tumors arising from epithelial TA cells. The ability to target these TA and stem cell pools can direct targeted oral chemoprevenetive strategies.
Stem cells and previous studies
There have been recent breakthroughs in stem cell research during the past decade that created many avenues for scientists and clinicians to better understand and apply gene therapy for human diseases. One of the major stem cell related discoveries was the identification of epidermal precursor stem cells (TA cells). These cells are not just located within the basal cell layer of the overlying epidermis, but more specifically reside within the bulge zone of the underlying associated hair follicles.
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The use of immunohistochemistry in both human and murine models established advancements for epidermal stem cell research. The use of keratin promoter markers K-5, K-14 and K-15 has provided researchers information regarding cellular homeostasis, development, wound healing and carcinogenesis with respect to the integumentary system. [17] [18] [19] [20] [21] [22] [23] Epidermal stem cells are located within the bulge zone of the associated hair follicles and not within the basal cell layer of the overlying epidermis. [13] [14] [15] While it is generally accepted that the oral mucosal stem cells reside within the basal cell layer, due to ethical concerns regarding cell labeling, these findings have not been substantiated in humans.
Skin wounds induce increased mitotic activity of bulge cells during wound repair. The minor salivary glands of the oral mucosa represent an analogous structure to the bulge zone of the hair follicle indicating activity within the salivary gland acini.
Bromodeoxyuridine
Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) is a synthetic nucleoside that is an analogue of thymidine. BrdU is commonly used in the detection of proliferating cells in living tissues. Incorporation of BrdU occurs during the S-phase of DNA synthesis and substitutes uridine for thymidine during replication. Consequently, BrdU is employed to detect actively replicating cells during DNA synthesis. Due to its ability to create DNA mutations, it's use is contraindicated in human subjects.
Keratin 15
Keratin 15 belongs to a superfamily of intermediate filamentous proteins. This filament composes part of the cytoskeleton comprised of 10-nm-diameter filaments and is largely found in stratified epithelium. This marker is most commonly expressed in stable and slowly replicating basal cell layer of skin and other tissues.
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Clusters of Differentiation
Clusters of differentiation, routinely abbreviated as CD, are various types of molecules such as receptors or ligands used to identify specific cell surface molecules that are defined by a certain set of monoclonal antibodies. 25 These protocols were introduced in 1982 and more than 300 types have been developed. 26 
CD135 (FLT3 Ligand)
According to the national library of medicine, CD 135 is receptor tyrosine kinase involved in hematopoesis. It is closely related to FMS proto-oncogene protein and is commonly mutated in acute myeloid leukemia. 41 CD 135 has been identified as a surface marker in multipotent and common lymphoid progenitors in bone marrow.
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Current Concepts in Stem Cell Therapy
Stem cell therapy is currently focused towards treatment of many diseases with underlying genetic perturbations and bone marrow derived disease processes. 44 These disease and diagnostic indications include:
• Parkinson's disease 45, 46 • Alzheimer diagnosis from bone marrow derived cells 47 • Bone marrow derived gastric cancer 48 • Kidney transplant associated skin carcinoma 49 • Leukemia diagnosis with CD135
41
• Isolation of progenitor cells in renal tissues 50 
Specific Aim
The purpose of this study was to determine the location(s) of the oral mucosal stem cell pool(s) using a murine model and concurrent human oral tissue evaluation..
Experimental Hypothesis
The acinar structures of the minor salivary glands harbor oral mucosal stem cells.
Null Hypothesis
The exclusive contributing cell to surface oral epithelium resides within the basal layer keratinocytes.
Chapter 2
Materials and Methods
Human Tissue Selection
We obtained ulcerated and intact human oral mucosal specimens from archived tissue from The Ohio State University Oral Pathology service. This study was in accordance with The Ohio State University Institutional Review Board (protocol #2007E0437).
Tissue specimens were selected based on abundance of minor salivary glands and presence of terminal salivary duct surface epithelium interface. Tissue procured was then analyzed using multiple stem cell markers.
Murine Tissue Selection
Animal procedures were conducted in accordance with The Ohio State University
Institutional Animal Care and Use Committee (IACUC). Authorization was approved and accepted on September 13 th 2006 (Protocol #2006A0174).
Our first goal was to determine the region of murine oral mucosa with the highest concentration of minor salivary glands. Three FVB mice heads from another study was used to biopsy selected oral cavity sites. Biopsies of the soft/hard palate, ventral tongue, buccal mucosa and floor of the mouth underwent tissue processing and light microscopic evaluation to determine which area contained the highest number of minor salivary glands.
Murine Model
This model involved fifteen eight week old male FVB mice, with a six day experimental period. All mice were provided water and food access ad libitum and housed under a 12-hour dark and 12-hour light cycle. The fifteen mice were randomly assigned in two separate groups, i.e. ten in the experimental group and five in the control group. On day one, the experimental group was anesthetized by intraperitoneal injection (IP) of ketamine (40mg/kg) and Xylazine (10mg/kg). Once appropriate anesthesia was obtained, the experimental group was wounded. An experienced oral and maxillofacial surgeon using a dental implant drill performed the wounding. The tissue was wounded at the soft palate, slightly to the right of the midline and posterior to the vibrating line. Each wound was approximately 3x3 mm in size. Next, all mice were injected with BrdU (50mg/kg IP at a concentration of 10mg/ml in 0.9% NaCl).
The following day (day 2), all mice were injected with the same dose and concentration of BrdU. Three hours later, three mice (two experimental and one control)
were euthanized and tissue samples were obtained as will be described. On day three, the remaining 12 mice will be injected with a third dose of BrdU and three more mice (two experimental and one control) will be euthanized and tissue sampled. This process will continued with all remaining mice receiving BrdU injections daily until euthanized (table   1) . 
Euthanizing protocol
The mice were anaesthetized as previously described. Once anesthesia has taken affect, the mice were placed in a 5 percent halothane chamber. Once asleep, the mice were euthanized by cervical dislocation. Death was confirmed by lack of cardiac function.
The palatal tissues were then dissected from the euthanized mice and immediately placed in formalin for tissue processing and experimental analysis.
Murine Anti-BrdU Immunohistochemistry Staining
Paraffin sections were heated in a 56°C oven for 90 minutes prior to hydration.
Deparaffinization and hydration was accomplished with histoclear, ethanol and distilled water. Endogenous peroxides were quenched using 3% hydrogen peroxide in methanol.
Samples were treated with trypsin (antigen masking) and incubated at 37°C for 30 
Murine Anti-K15 immunohistochemistry with VIP
Prepared paraffin sections were heated in a 56°C oven for 90 minutes prior to hydration.
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20 minute room air cooling. Next, samples were blocked for 60 minutes with 5% normal goat serum, 1% BSA, 0.05% Tween 20 in PBS. Sections were then incubated at 4°C overnight with primary chicken anti-K15 polyclonal antibody (from COVANCE, cat# PCK-153P, stored at -20 o C). Next, slides were incubated for 1 hour with 7.5µg/ml biotinylated secondary antibody solution
(1:200 dilution) at RT (Goat anti-Chicken IgG (H+L), 1.5mg/ml from VECTOR). Slides were then treated for 30 minutes with VECTASTAIN ABC followed by VIP staining.
Counterstaining was preformed with pre-heated methyl green for 5 minutes. Lastly, slides were dehydrated and cleared for visual inspection.
Murine CD34 Immunohistochemistry with VIP
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20 minute room air cooling. Next, samples were blocked for 60 minutes with 5% normal rabbit serum, 1% BSA, 0.05% Tween 20 in PBS. Sections were then incubated at 4°C overnight with CD34 rat monoclonal antibody (Santa Cruz, cat #sc-52478, stored at 4°C). Next, slides were incubated for 1 hour with 7.5µg/ml biotinylated secondary antibody solution (1:200 dilution) at RT (Rabbit anti-rat IgG (H+L), 1.5mg/ml from VECTOR). Slides were then treated for 30 minutes with VECTASTAIN ABC followed by VIP staining.
Murine CD135 Immunohistochemistry with VIP
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20-minute room air-cooling. Prepared paraffin sections were heated in a 56°C oven for 90 minutes prior to hydration.
Human CD34 immunohistochemistry with DAB
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20-minute room air-cooling. Next, samples were blocked for 60 minutes with 5% normal hourse serum, 1% BSA, 0.05% Tween 20 in PBS. Sections were then incubated at 4°C overnight with anti-human CD34 mouse monoclonal antibody (BioGenex, cat# MU236-UC, stored at 4°C). Next, slides were incubated for 1 hour with 7.5µg/ml biotinylated secondary antibody solution
(1:200 dilution) at RT (Horse anti-mouse IgG (H+L), 1.5mg/ml from VECTOR). Slides were then treated for 30 minutes with VECTASTAIN ABC followed by DAB staining.
Counterstaining was preformed with pre-heated methyl green for 5 minutes. Lastly, slides were dehydrated and cleared for visual inspection
Human CD133 immunohistochemistry with DAB
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20-minute room air-cooling. Next, samples were blocked for 60 minutes with 5% normal rabbit serum, 1% BSA, 0.05% Tween 20 in PBS. Sections were then incubated at 4°C overnight with CD 133 rabbit polyclonal antibody (from abcam, cat# ab19898, stored at 4°C). Next, slides were incubated for 1 hour with 7.5µg/ml biotinylated secondary antibody solution (1:200 dilution) at RT (Goat anti-rabbit IgG (H+L), 1.5mg/ml from VECTOR). Slides were then treated for 30 minutes with VECTASTAIN ABC followed by DAB staining.
Image Pro Analysis
Quantitative analysis of both BrdU and K15 were used with subjective identification of the most active portion of the epidermis. Once identified, the epidermis was outlined using image pro plus software with 200x magnification for all specimens. The positively stained cells were highlighted and compared to the selected overall area of the epidermis as a quantitative percentage. suggests that there is residual or sustained mutations within the stem cell pool that leads to these recurrences. As our purpose suggests, our ability to identify the existence of these stem cells will eventually lead to a target zone for chemotherapy.
The purpose of this study was to determine the location(s) of the oral mucosal stem cell pool(s). Identifying the oral stem cell pool could have a twofold purpose. First, these data would be of scientific interest from a biological perspective and secondly the precise localization of these cells can provide valuable clinical perspective for treatment modalities.
Materials and Methods
To address our question, we employed: 1) a murine oral mucosal wound healing model (wounding initiates stem cell proliferation), 2) human oral mucosal biopsies of ulcers overlying minor salivary glands. Immunohistochemical markers employed were: 1) K15
(primitive keratinocytes), 2) BrdU (thymidine analogue indicative of DNA synthesis), 3)
CD34 (reported as an epidermal stem cell marker), 4) CD133 (hematopoietic and general stem markers). 
Human Tissue Sampling
Human Anti-K15 immunohistochemistry with VIP
Human CD34 immunohistochemistry with DAB
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20-minute room air-cooling. Next, samples were blocked for 60 minutes with 5% normal horse serum, 1% BSA, 0.05% Tween 20 in PBS. Sections were then incubated at 4°C overnight with anti-human CD34 mouse monoclonal antibody (BioGenex, cat# MU236-UC, stored at 4°C). Next, slides were incubated for 1 hour with 7.5µg/ml biotinylated secondary antibody solution
Human CD133 immunohistochemistry with DAB (Abcam)
Murine Tissue Selection
Murine protocol was in accordance with IACUC (Protocol #2006A0174).
The goal to find the region of oral mucosa with the highest concentration of minor salivary glands was obtained using a murine model. Three FVB mice heads from a previous study was obtained and biopsied from various sites. Sampling of the soft/hard palate, ventral tongue, buccal mucosa and floor of the mouth was evaluated histologically to determine which area contained the highest amounts of minor salivary glands.
Murine Model
This model involves fifteen eight week old male FVB mice used over a six-day period.
All mice were provided water and food access ad libitum and housed under a 12-hour dark and 12-hour light cycle. The fifteen mice were categorized in two separate groups.
Ten in the experimental group and five in the control group. On day one, the experimental group was anestisized by intraperitoneal injection of ketamine (40mg/kg) and Xylazine (10mg/kg). Once appropriate anesthesia was obtained, the experimental group was wounded. An experienced oral and maxillofacial surgeon using a dental implant drill performed the wounding. The tissue was wounded at the soft palate, slightly to the right of the midline and posterior to the vibrating line. Each wound was approximately 3x3 mm in size. Next, All mice were injected with BrdU (50mg/kg IP at a concentration of 10mg/ml in 0.9% NaCl).
were euthanized and tissue samples were obtained as will be described. On day three, the remaining 12 mice were injected with a third dose of BrdU and three more mice (two experimental and one control) were euthanized and tissue sampled. This process will continue daily with all remaining mice receiving BrdU injections until euthanized (table   1) .
Murine Anti-Brdu immunohistochemistry
Deparaffinization and hydration was accomplished with histoclear, ethanol and distilled water. Endogenous peroxides were quenched using 3% hydrogen peroxide in methanol. 
Murine Anti-K15 immunohistochemistry with VIP
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20-minute room air-cooling. Next, samples were blocked for 60 minutes with 5% normal goat serum, 1% BSA, 0.05% Tween 20 in PBS. Sections were then incubated at 4°C overnight with primary chicken anti-K15 polyclonal antibody (from COVANCE, cat# PCK-153P, stored at -20 o C). Next, slides were incubated for 1 hour with 7.5µg/ml biotinylated secondary antibody solution
Murine CD34 Immunohistochemistry with VIP
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20-minute room air-cooling. Next, samples were blocked for 60 minutes with 5% normal rabbit serum, 1% BSA, 0.05% Tween 20 in PBS. Sections were then incubated at 4°C overnight with CD34 rat monoclonal antibody (Santa Cruz, cat #sc-52478, stored at 4°C). Next, slides were incubated for 1 hour with 7.5µg/ml biotinylated secondary antibody solution (1:200 dilution) at RT (Rabbit anti-rat IgG (H+L), 1.5mg/ml from VECTOR). Slides were then treated for 30 minutes with VECTASTAIN ABC followed by VIP staining.
Murine CD135 Immunohistochemistry with VIP
Samples were then treated with antigen retrieval using a 10mM Citrate buffer by heating samples for 7 minutes in a microwave, followed by a 20-minute room air-cooling. 
Quantitative Image Analysis
Quantitative analysis of both BrdU and K15 were used with subjective identification of the most active portion of the epidermis. Once identified, the epidermis was outlined using software techniques. The positively stained cells were highlighted and compared to the selected overall area of the epidermis as a quantitative percentage.
Results
Human K15 immunohistochemistry with VIP
Immunohistochemistry demonstrated positive staining of K15 cells within the basal cell layer with obvious activity along the terminal ducts of minor salivary glands (Figure 2 ).
This activity was noted on multiple samples of human tissue containing a communication between epithelium and salivary gland ductal tissue. 
Murine Tissue Selection
Routine histological review identified that the hard/soft palate junction of mice contain the highest concentration of minor salivary glands, followed by the floor of mouth, then buccal mucosa and finally the ventral tongue containing the fewest amounts of minor salivary glands. These findings were determined by routine H&E staining protocols.
Mouse Anti-Brdu immunohistochemistry
Injured murine mucosa highlighted intense staining along the epithelium and connective tissue when compared to non-injured control mice. Increased activity along all the acinar of injured murine mucosa also induced more activity when compared to control murine mucosa (figure 5a and 5b). 
Mouse CD135 Immunohistochemistry with VIP
Many attempts were made to stain murine mucosa with CD135 but only background staining was obtained and no evidence of epithelial or endothelial staining was evident.
Quantitative Image Analysis
Image Pro software was used for evaluation methods of non-injured and injured mice stained with K15 and BrdU. Positive stained cells within the most active area of epithelium were isolated and compared to the entire surface area. Both K15 and BrdU showed higher activity along the epithelium and salivary ducts in the injured tissue when compared to the non-injured tissue (table 2) .
Legend:
Comparison for BrdU quantitative and qualitative differences using image analysis software. These data show enhanced proliferation in the wounded specimens relative to matched control non wounded murine tissue. Table 2 W=Wounded C= Non wounded control
Mouse
Discussion
Human Tissue Staining
The inability to employ in vivo cell labeling techniques to target actively replicating human cells requires alternate techniques to help identify actively dividing stem cells in human tissues. While, the analogy of the skin hair bulge to the mucosal salivary duct is feasible, no studies have attempted to compare these structures. We used similar dermatologic protocols to stain human mucosa that identified positive K15 staining along human ulcerated epithelium with involvement of the salivary acini. [13] [14] [15] [16] [17] [18] [19] [20] It is prudent to think that K15 alone would specify the location of TA cells because this marker highlights type I cytokeratin found in primitive progenitor basal cells and since oral mucosa is a highly active, self-renewing system that is under constant turnover, one would expect positive staining activity in both injured and non-injured tissues. 4 CD34 and CD133 positivity within the acinar structures represents primitive stem cell activity.
Murine Tissue Staining
The ability to track these cells from their origin creates difficult challenges since injecting humans and performing label-retaining studies is not ethical. An alternative was the development of a murine model to further exploration these findings. Table 2 . Activity along the ducts was clearly identified at a greater rate in the injured murine subjects with both markers.
To further probe the identification of the TA cell pool in the murine model we incorporated CD34, CD133 and CD135 staining. The use of CD34 reinforces previous studies of mast cell identification and provided minimal input for identification of the desired stem cell pool. 33 CD133 and CD135 staining of the murine tissues displayed many challenges. Multiple attempts were made using different antibodies, block out agents and concentrations, but no results could be obtained from these markers in the murine model, which is consistent with previous attempts in mice. 51 5.
Conclusion
The current data imply that selected salivary gland acini are comparable to the bulge zone of the hair follicle and these cells contribute to the oral mucosal stem cell pool. Further, the localization of either of these cell pools may lead to advancements in cancer treatment and help direct chemoprevention.
Chapter 4 Conclusion
The future of this study requires further specification of the TA pool of stem cells in the oral cavity in both the murine and human models. Recent literature suggests a promising marker that may provide more insight on TA cells location. Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) has been expressed in ocular limbal cells, intestinal epithelium and hair follicles using murine models and human specimens.
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The ultimate goal is to identify the origin of the TA and stem cells that serve the oral cavity. The likely source as previously discussed is hematopoietic lineage. The next avenue to pursue includes label retaining stem cells that can be used in a murine model to identify and track TA cells from bone marrow to the oral cavity.
